Company / Depreciation & Amortization
Elanco Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$680.0M
FY2025
5-year range
$662.0M / $716.0M
FY2021-FY2025
Trend
+2.7%
vs FY2024
Sector context
#10 of 168
Health Care
What the data says
Among 168 Health Care companies, Elanco is in the bottom 6% for depreciation & amortization. Depreciation & Amortization has fluctuated over the past 10 years, ranging from $254M in FY2016 to $716M in FY2021.
Based on SEC 10-K filings.
$680M in FY2025 with a 5-year CAGR of +5.6%. Top quartile in the Health Care sector.
Improved from $694M to $680M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -0.1%
- 5-Year CAGR
- +5.6%
- 10-Year CAGR
- -
Sector benchmark
+219.4% above sector average
Key checks
Key Insights
- 5-year CAGR of +5.6%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 2.7% year-over-year.
- Ranks #10 out of 168 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $680.0M | +2.7% |
| FY2024 | $662.0M | -4.6% |
| FY2023 | $694.0M | +1.8% |
| FY2022 | $682.0M | -4.7% |
| FY2021 | $716.0M | +38.5% |
| FY2020 | $517.0M | +64.6% |
| FY2019 | $314.0M | +6.1% |
| FY2018 | $296.0M | -7.0% |
| FY2017 | $318.4M | +25.2% |
| FY2016 | $254.4M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026